Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rifomycin IX. Two new antibiotics of rifomycin family: rifomycin S and rifomycin SV. Preliminary report.

Authors: A F D Di Stefano; A Rusca; L Loprete; M J Dröge; L Moro; A Assandri
Journal: Antimicrob Agents Chemother Date: 2011-03-14 Impact factor: 5.191

Review 4. Rifamycin antibiotics and the mechanisms of their failure.

Authors: Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal: J Antibiot (Tokyo) Date: 2021-08-16 Impact factor: 2.649

5. Rifomycin. XIV. Production of rifomycin B.

Authors: P MARGALITH; H PAGANI
Journal: Appl Microbiol Date: 1961-07

6. Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX^® Modified Release Tablets in Healthy Male and Female Volunteers.

Authors: Andrea Francesco Daniele Di Stefano; Milko Massimiliano Radicioni; Angelo Vaccani; Alessandro Mazzetti; Luigi Maria Longo; Luigi Moro
Journal: Antibiotics (Basel) Date: 2021-02-06

6 in total

Rifomycin IX. Two new antibiotics of rifomycin family: rifomycin S and rifomycin SV. Preliminary report.

1. Rifomycin. V. Rifomycin O, a new antibiotic of the rifomycin family.

1. Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.

Review 2. Actions of the rifamycins.

3. Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers.

Review 4. Rifamycin antibiotics and the mechanisms of their failure.

5. Rifomycin. XIV. Production of rifomycin B.

6. Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX® Modified Release Tablets in Healthy Male and Female Volunteers.

6. Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX^® Modified Release Tablets in Healthy Male and Female Volunteers.